VEGF protein and mRNA expression in diabetic Gal-3 and WT mouse retina
Copyright information:Taken from "Inhibition of Advanced Glycation and Absence of Galectin-3 Prevent Blood-Retinal Barrier Dysfunction during Short-Term Diabetes"Experimental Diabetes Research 2007;2007():-.Published online 12 Apr 2007PMCID:PMC1880865. In WT mice (black bars) VEGF expressi...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Bild |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | Canning, Paul Glenn, Josephine V. Hsu, Daniel K. Fu-Tong Liu Gardiner, Tom A. Stitt, Alan W. |
description | Copyright information:Taken from "Inhibition of Advanced Glycation and Absence of Galectin-3 Prevent Blood-Retinal Barrier Dysfunction during Short-Term Diabetes"Experimental Diabetes Research 2007;2007():-.Published online 12 Apr 2007PMCID:PMC1880865. In WT mice (black bars) VEGF
expression is significantly increased in diabetic (DB) retina—in
terms of both protein (a) and mRNA expression (b) when compared to
nondiabetic controls (NDB). PM-treatment significantly reduces
VEGF expression in diabetic mice. In Gal-3 mice (white
bars), retinal expression levels are not as dramatically increased
by the presence of diabetes as evidenced in WT mice. |
doi_str_mv | 10.6084/m9.figshare.16645 |
format | Image |
fullrecord | <record><control><sourceid>datacite_PQ8</sourceid><recordid>TN_cdi_datacite_primary_10_6084_m9_figshare_16645</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_6084_m9_figshare_16645</sourcerecordid><originalsourceid>FETCH-datacite_primary_10_6084_m9_figshare_166453</originalsourceid><addsrcrecordid>eNpjYJA0NNAzM7Aw0c-11EvLTC_OSCxK1TM0MzMx5WRwC3N1d1MoKMovSc3MU0jMS1HIDfJzVEitKChKLS7OzM9TAAqnZCYmpZZkJiu4J-boGoNVhYco5OaXFqcqFAEl8hJ5GFjTEnOKU3mhNDeDoZtriLOHbkpiSWJyZklqfEFRZm5iUWW8oUE8yC3xuZbxMLfEg91iTI4eAEIgRT0</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>image</recordtype></control><display><type>image</type><title>VEGF protein and mRNA expression in diabetic Gal-3 and WT mouse retina</title><source>DataCite</source><creator>Canning, Paul ; Glenn, Josephine V. ; Hsu, Daniel K. ; Fu-Tong Liu ; Gardiner, Tom A. ; Stitt, Alan W.</creator><creatorcontrib>Canning, Paul ; Glenn, Josephine V. ; Hsu, Daniel K. ; Fu-Tong Liu ; Gardiner, Tom A. ; Stitt, Alan W.</creatorcontrib><description>Copyright information:Taken from "Inhibition of Advanced Glycation and Absence of Galectin-3 Prevent Blood-Retinal Barrier Dysfunction during Short-Term Diabetes"Experimental Diabetes Research 2007;2007():-.Published online 12 Apr 2007PMCID:PMC1880865. In WT mice (black bars) VEGF
expression is significantly increased in diabetic (DB) retina—in
terms of both protein (a) and mRNA expression (b) when compared to
nondiabetic controls (NDB). PM-treatment significantly reduces
VEGF expression in diabetic mice. In Gal-3 mice (white
bars), retinal expression levels are not as dramatically increased
by the presence of diabetes as evidenced in WT mice.</description><identifier>DOI: 10.6084/m9.figshare.16645</identifier><language>eng</language><publisher>Figshare</publisher><subject>Molecular Biology</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>776,1888</link.rule.ids><linktorsrc>$$Uhttps://commons.datacite.org/doi.org/10.6084/m9.figshare.16645$$EView_record_in_DataCite.org$$FView_record_in_$$GDataCite.org$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Canning, Paul</creatorcontrib><creatorcontrib>Glenn, Josephine V.</creatorcontrib><creatorcontrib>Hsu, Daniel K.</creatorcontrib><creatorcontrib>Fu-Tong Liu</creatorcontrib><creatorcontrib>Gardiner, Tom A.</creatorcontrib><creatorcontrib>Stitt, Alan W.</creatorcontrib><title>VEGF protein and mRNA expression in diabetic Gal-3 and WT mouse retina</title><description>Copyright information:Taken from "Inhibition of Advanced Glycation and Absence of Galectin-3 Prevent Blood-Retinal Barrier Dysfunction during Short-Term Diabetes"Experimental Diabetes Research 2007;2007():-.Published online 12 Apr 2007PMCID:PMC1880865. In WT mice (black bars) VEGF
expression is significantly increased in diabetic (DB) retina—in
terms of both protein (a) and mRNA expression (b) when compared to
nondiabetic controls (NDB). PM-treatment significantly reduces
VEGF expression in diabetic mice. In Gal-3 mice (white
bars), retinal expression levels are not as dramatically increased
by the presence of diabetes as evidenced in WT mice.</description><subject>Molecular Biology</subject><fulltext>true</fulltext><rsrctype>image</rsrctype><creationdate>2011</creationdate><recordtype>image</recordtype><sourceid>PQ8</sourceid><recordid>eNpjYJA0NNAzM7Aw0c-11EvLTC_OSCxK1TM0MzMx5WRwC3N1d1MoKMovSc3MU0jMS1HIDfJzVEitKChKLS7OzM9TAAqnZCYmpZZkJiu4J-boGoNVhYco5OaXFqcqFAEl8hJ5GFjTEnOKU3mhNDeDoZtriLOHbkpiSWJyZklqfEFRZm5iUWW8oUE8yC3xuZbxMLfEg91iTI4eAEIgRT0</recordid><startdate>20111230</startdate><enddate>20111230</enddate><creator>Canning, Paul</creator><creator>Glenn, Josephine V.</creator><creator>Hsu, Daniel K.</creator><creator>Fu-Tong Liu</creator><creator>Gardiner, Tom A.</creator><creator>Stitt, Alan W.</creator><general>Figshare</general><scope>DYCCY</scope><scope>PQ8</scope></search><sort><creationdate>20111230</creationdate><title>VEGF protein and mRNA expression in diabetic Gal-3 and WT mouse retina</title><author>Canning, Paul ; Glenn, Josephine V. ; Hsu, Daniel K. ; Fu-Tong Liu ; Gardiner, Tom A. ; Stitt, Alan W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-datacite_primary_10_6084_m9_figshare_166453</frbrgroupid><rsrctype>images</rsrctype><prefilter>images</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Molecular Biology</topic><toplevel>online_resources</toplevel><creatorcontrib>Canning, Paul</creatorcontrib><creatorcontrib>Glenn, Josephine V.</creatorcontrib><creatorcontrib>Hsu, Daniel K.</creatorcontrib><creatorcontrib>Fu-Tong Liu</creatorcontrib><creatorcontrib>Gardiner, Tom A.</creatorcontrib><creatorcontrib>Stitt, Alan W.</creatorcontrib><collection>DataCite (Open Access)</collection><collection>DataCite</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Canning, Paul</au><au>Glenn, Josephine V.</au><au>Hsu, Daniel K.</au><au>Fu-Tong Liu</au><au>Gardiner, Tom A.</au><au>Stitt, Alan W.</au><format>book</format><genre>unknown</genre><ristype>GEN</ristype><title>VEGF protein and mRNA expression in diabetic Gal-3 and WT mouse retina</title><date>2011-12-30</date><risdate>2011</risdate><abstract>Copyright information:Taken from "Inhibition of Advanced Glycation and Absence of Galectin-3 Prevent Blood-Retinal Barrier Dysfunction during Short-Term Diabetes"Experimental Diabetes Research 2007;2007():-.Published online 12 Apr 2007PMCID:PMC1880865. In WT mice (black bars) VEGF
expression is significantly increased in diabetic (DB) retina—in
terms of both protein (a) and mRNA expression (b) when compared to
nondiabetic controls (NDB). PM-treatment significantly reduces
VEGF expression in diabetic mice. In Gal-3 mice (white
bars), retinal expression levels are not as dramatically increased
by the presence of diabetes as evidenced in WT mice.</abstract><pub>Figshare</pub><doi>10.6084/m9.figshare.16645</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | DOI: 10.6084/m9.figshare.16645 |
ispartof | |
issn | |
language | eng |
recordid | cdi_datacite_primary_10_6084_m9_figshare_16645 |
source | DataCite |
subjects | Molecular Biology |
title | VEGF protein and mRNA expression in diabetic Gal-3 and WT mouse retina |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T02%3A41%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-datacite_PQ8&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.au=Canning,%20Paul&rft.date=2011-12-30&rft_id=info:doi/10.6084/m9.figshare.16645&rft_dat=%3Cdatacite_PQ8%3E10_6084_m9_figshare_16645%3C/datacite_PQ8%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |